The story of Viagra and its impact on the pharmaceutical sector presents a complex question regarding its continued viagra attractiveness as an investment. Initially a remarkable success, generating billions , generic competition has substantially eroded profit margins . While established pharmaceutical firms maintain patents on related therapies a

The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced considerable risk . Investors are now assessing the consequences of rival medications , dim